Identification of latent membrane protein 2A (LMP2A) specific targets for treatment and eradication of Epstein-Barr virus (EBV)-associated diseases.
Swanson-Mungerson
Michelle
M
Department of Microbiology and Immunology, Northwestern University Medical School, Chicago, IL 60611, USA.
Ikeda
Masato
M
Lev
Lori
L
Longnecker
Richard
R
Portis
Toni
T
D000818:Animals; D016503:Drug Delivery Systems / Q000379:methods*; D020031:Epstein-Barr Virus Infections / Q000188:drug therapy* / Q000235:genetics*; D004854:Herpesvirus 4, Human / Q000187:drug effects / Q000235:genetics*; D006801:Humans; D020411:Oligonucleotide Array Sequence Analysis / Q000379:methods; D014763:Viral Matrix Proteins / Q000235:genetics / Q000302:isolation & purification* / Q000378:metabolism
C037662:EBV-associated membrane antigen, Epstein-Barr virus; D014763:Viral Matrix Proteins